65 related articles for article (PubMed ID: 6838287)
1. Ketanserin, a new selective 5-HT2 receptor blocking agent, inhibits the antidiuretic effect of 5-hydroxytryptamine (5-HT) in Wistar rats.
Cantalamessa F; de Caro G; Massi M; Micossi LG
Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):302-7. PubMed ID: 6838287
[No Abstract] [Full Text] [Related]
2. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
Lucki I; Nobler MS; Frazer A
J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
[TBL] [Abstract][Full Text] [Related]
3. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
Kalkman HO; Engel G; Hoyer D
J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
[TBL] [Abstract][Full Text] [Related]
4. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent.
Persson B; Hedner T; Henning M
J Pharm Pharmacol; 1982 Jul; 34(7):442-5. PubMed ID: 6126541
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
Aono J; Nabata H; Ishizuka N; Sakai K
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of the bronchial artery to 5-hydroxytryptamine.
Ei-Fawal HA; Ogunbiyi PO; Gordon V; Eyre P
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):325-36. PubMed ID: 2934778
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
Marek GJ; Seiden LS
J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of the 5-HT-induced bronchoconstriction in the cat.
Reiche R; Frey HH
Arch Int Pharmacodyn Ther; 1983 May; 263(1):139-45. PubMed ID: 6615080
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
Kendall DA; Nahorski SR
J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487
[TBL] [Abstract][Full Text] [Related]
12. The effect of a selective 5-HT2 antagonist, ketanserin, on the pulmonary responses to Escherichia coli endotoxin.
Ball HA; Parratt JR; Rodger IW
Br J Pharmacol; 1983 Oct; 80(2):295-301. PubMed ID: 6360280
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin.
Verheyen A; Vlaminckx E; Lauwers F; Van Den Broeck C; Wouters L
Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):280-98. PubMed ID: 6486974
[TBL] [Abstract][Full Text] [Related]
14. Central serotonin antagonist activity of ketanserin.
Fuller RW; Snoddy HD
Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):151-4. PubMed ID: 6505385
[TBL] [Abstract][Full Text] [Related]
15. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat.
Docherty JR; Warnock P
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine (serotonin) enhances ventricular arrhythmias induced by acute coronary artery ligation in rats.
el-Mahdy SA
Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):383-6. PubMed ID: 2117299
[TBL] [Abstract][Full Text] [Related]
17. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
Williams BC; Shaikh S; Edwards CR
J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
[TBL] [Abstract][Full Text] [Related]
19. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
Ogunbiyi PO; Eyre P
Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition by ketanserin and spiroperidol of 5-HT-induced myometrial contraction.
Ichida S; Hayashi T; Terao M
Eur J Pharmacol; 1983 Dec; 96(1-2):155-8. PubMed ID: 6662193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
